These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2213071)

  • 1. Drug banning and the regulatory process.
    Faich GA
    J Clin Epidemiol; 1990; 43(9):1014-6. PubMed ID: 2213071
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory concerns at various phases of drug development.
    Aurecchia S; Orloff D; Sobel S
    Am J Cardiol; 1998 Apr; 81(8A):2F-4F. PubMed ID: 9604895
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA reforms drug approval system.
    Hayes AH
    US Med; 1983 Jan; 19(2):41-2. PubMed ID: 10259319
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigational new drug regs: icing or cake?
    Margolis RE
    Healthspan; 1988 Dec; 5(11):25-6. PubMed ID: 10291398
    [No Abstract]   [Full Text] [Related]  

  • 5. The regulation of investigational drugs.
    Kessler DA
    N Engl J Med; 1989 Feb; 320(5):281-8. PubMed ID: 2643051
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge of regulating development and approval of drugs with pleiotropic action in cardiovascular disease.
    Temple R
    Am J Cardiol; 1998 Apr; 81(8A):5F-9F. PubMed ID: 9604896
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory watch: Innovative drug availability in China.
    Shao L; Xu L; Li Q; Chakravarthy R; Yang Z; Kaitin KI
    Nat Rev Drug Discov; 2016 Nov; 15(11):739-740. PubMed ID: 27765941
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approach to the regulation of drugs for diabetes.
    Fleming A
    Am Heart J; 1999 Nov; 138(5 Pt 1):S338-45. PubMed ID: 10539795
    [No Abstract]   [Full Text] [Related]  

  • 9. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues.
    Birnkrant D
    AIDS; 2001 Feb; 15 Suppl 1():S68-9. PubMed ID: 11407326
    [No Abstract]   [Full Text] [Related]  

  • 10. The drug regulation process and the challenge of regulatory reform.
    Dorsen N; Miller JM
    Ann Intern Med; 1979 Dec; 91(6):908-13. PubMed ID: 517893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory science and the role of the regulator in biomedical innovation.
    Honig PK; Huang SM
    Clin Pharmacol Ther; 2012 Mar; 91(3):347-52. PubMed ID: 22343804
    [No Abstract]   [Full Text] [Related]  

  • 12. Analgesics pose regulatory challenge to FDA.
    Thompson CA
    Am J Health Syst Pharm; 2009 Aug; 66(16):1426, 1428. PubMed ID: 19666997
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory controversy surrounding ipecac use and misuse.
    Brushwood DB; Tietze KJ
    Am J Hosp Pharm; 1986 Jan; 43(1):157-61. PubMed ID: 2869686
    [No Abstract]   [Full Text] [Related]  

  • 14. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 16. Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug Administration.
    Feinsod M; Chambers WA
    Ophthalmology; 2004 Oct; 111(10):1801-6. PubMed ID: 15465539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sick agency in need of a cure? Recall of a popular pain drug has focused attention on government drug regulation.
    Spake A
    US News World Rep; 2004 Dec; 137(21):32-3, 36. PubMed ID: 15636503
    [No Abstract]   [Full Text] [Related]  

  • 18. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTC or not OTC--that is the question.
    Parmley WW
    J Am Coll Cardiol; 2000 Oct; 36(4):1426-7. PubMed ID: 11028505
    [No Abstract]   [Full Text] [Related]  

  • 20. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.